Aβ42 Peptide Promotes Proliferation and Gliogenesis in Human Neural Stem Cells

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Amyloid-β 42 (Aβ42) is implicated in Alzheimer's disease (AD) pathology.
• The physiological role of Aβ42 in brain development and function remains controversial.
• Understanding Aβ42's effects on neural stem cells is crucial for AD research.

Purpose of the Study:

• To investigate the concentration-dependent effects of monomeric Aβ42 on human neural stem cells (hNSCs).
• To analyze Aβ42's impact on cell death, proliferation, and differentiation in hNSCs.
• To explore the molecular mechanisms underlying Aβ42's effects, focusing on GSK3β.

Main Methods:

• Treatment of hNS1 cell line with varying concentrations of monomeric Aβ42.
• Assessment of cell death, DNA damage, and proliferation.
• Analysis of cell fate specification, including neuronal and glial differentiation.
• Evaluation of GSK3β expression and the effect of its inhibition.

Main Results:

• High Aβ42 concentrations (1 μM) induced neurotoxicity, increasing apoptotic cell death and DNA damage.
• Low Aβ42 concentrations promoted hNSC proliferation and glial cell specification in a dose-dependent manner.
• Aβ42 increased GSK3β expression, and GSK3β inhibition blocked Aβ42-induced glial specification.
• Neuronal differentiation was not significantly affected by Aβ42 treatment.

Conclusions:

• Aβ42 exhibits concentration-dependent effects on neural stem cells, with low doses being potentially beneficial for glial development.
• GSK3β is involved in mediating Aβ42's effects on glial cell specification.
• These findings provide insights into early pathophysiological processes in AD and potential therapeutic targets.